Trail and kidney disease.
TNF-related apoptosis-inducing ligand (TRAIL, TNFSF10) is a cytokine belonging to the TNF superfamily that has been recently linked to the pathogenesis of diabetic nephropathy. TRAIL may modulate cell survival and proliferation through interaction with two different receptors, TRAIL-R1 and TRAIL-R2, and the actions of TRAIL are regulated by three decoy receptors, TRAIL-R3, TRAIL-R4 and osteoprotegerin. Both TRAIL and their receptors are expressed by renal cells. In diabetic nephropathy the glomerular and tubulointerstitial expression of TRAIL is increased, and in tubular cells proinflammatory cytokines enhance TRAIL expression. Additionally, a high glucose microenvironment sensitizes tubular cells to apoptosis induced by TRAIL. Renal expression of OPG is increased in diabetic nephropathy and OPG counteracts the actions of TRAIL in cultured cells. Overall these data point to a role of TRAIL in the pathogenesis of diabetic nephropathy through interactions with other cytokines and hyperglycemia.
Lorz
Corina
C
Renal and Vascular Research Laboratory, Fundacion Jimenez Diaz-UAM, Madrid, Spain. clorz@ciemat.es
Benito
Alberto
A
Ucero
Alvaro C
AC
Santamaría
Beatriz
B
Ortiz
Alberto
A
D006801:Humans; D007668:Kidney / Q000378:metabolism; D007674:Kidney Diseases / Q000378:metabolism / Q000503:physiopathology*; D053220:Receptors, TNF-Related Apoptosis-Inducing Ligand / Q000378:metabolism / Q000502:physiology*; D053221:TNF-Related Apoptosis-Inducing Ligand / Q000378:metabolism / Q000502:physiology*
D053220:Receptors, TNF-Related Apoptosis-Inducing Ligand; D053221:TNF-Related Apoptosis-Inducing Ligand; C505653:TNFSF10 protein, human